Cite
EGLN Inhibition Enables Dose-Escalated Radiation and Improves Survival Through Reduced GI Toxicity and Reduced Micrometastases
MLA
Amit Deorukhkar, et al. “EGLN Inhibition Enables Dose-Escalated Radiation and Improves Survival Through Reduced GI Toxicity and Reduced Micrometastases.” International Journal of Radiation Oncology*Biology*Physics, vol. 99, Oct. 2017, pp. E619–20. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2017.06.2095.
APA
Amit Deorukhkar, Lauren E. Colbert, Y. Huang, L. Baseler, Cullen M. Taniguchi, Tara N. Fujimoto, & Jessica M. Molkentine. (2017). EGLN Inhibition Enables Dose-Escalated Radiation and Improves Survival Through Reduced GI Toxicity and Reduced Micrometastases. International Journal of Radiation Oncology*Biology*Physics, 99, E619–E620. https://doi.org/10.1016/j.ijrobp.2017.06.2095
Chicago
Amit Deorukhkar, Lauren E. Colbert, Y. Huang, L. Baseler, Cullen M. Taniguchi, Tara N. Fujimoto, and Jessica M. Molkentine. 2017. “EGLN Inhibition Enables Dose-Escalated Radiation and Improves Survival Through Reduced GI Toxicity and Reduced Micrometastases.” International Journal of Radiation Oncology*Biology*Physics 99 (October): E619–20. doi:10.1016/j.ijrobp.2017.06.2095.